Literature DB >> 30649922

miR-222 represses expression of zipcode binding protein-1 and phospholipase C-γ1 in intestinal epithelial cells.

Li-Ping Jiang1, Shelley R Wang1,2, Hee Kyoung Chung1,2, Saharsh Buddula1, Jian-Ying Wang1,2,3, Jaladanki N Rao1,2.   

Abstract

Both zipcode binding protein-1 (ZBP1) and phospholipase C-γ1 (PLCγ1) are intimately involved in many aspects of early intestinal mucosal repair after acute injury, but the exact mechanisms that control their cellular abundances remain largely unknown. The present study shows that microRNA-222 (miR-222) interacts with the mRNAs encoding ZBP1 and PLCγ1 and regulates ZBP1 and PLCγ1 expression in intestinal epithelial cells (IECs). The biotinylated miR-222 bound specifically to the ZBP1 and PLCγ1 mRNAs in IECs. Ectopically expressed miR-222 precursor destabilized the ZBP1 and PLCγ1 mRNAs and consequently lowered the levels of cellular ZBP1 and PLCγ1 proteins. Conversely, decreasing the levels of cellular miR-222 by transfection with its antagonism increased the stability of the ZBP1 and PLCγ1 mRNAs and increased the levels of ZBP1 and PLCγ1 proteins. Overexpression of miR-222 also inhibited cell migration over the wounded area, which was partially abolished by overexpressing ZBP1 and PLCγ1. Furthermore, prevention of the increased levels of ZBP1 and PLCγ1 in the miR-222-silenced cells by transfection with specific small interfering RNAs targeting ZBP1 or PLCγ1 mRNA inhibited cell migration after wounding. These findings indicate that induced miR-222 represses expression of ZBP1 and PLCγ1 at the posttranscriptional level, thus inhibiting IEC migration during intestinal epithelial restitution after wounding.

Entities:  

Keywords:  HCT 116 cells; cell migration; early rapid repair; mRNA stability; microRNAs; mucosal injury; posttranscriptional regulation

Mesh:

Substances:

Year:  2019        PMID: 30649922      PMCID: PMC6457099          DOI: 10.1152/ajpcell.00165.2018

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   5.282


  57 in total

1.  JunD enhances miR-29b levels transcriptionally and posttranscriptionally to inhibit proliferation of intestinal epithelial cells.

Authors:  Tongtong Zou; Jaladanki N Rao; Lan Liu; Lan Xiao; Hee Kyoung Chung; Yanwu Li; Gang Chen; Myriam Gorospe; Jian-Ying Wang
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-18       Impact factor: 4.249

2.  A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility.

Authors:  Martijn Kedde; Marieke van Kouwenhove; Wilbert Zwart; Joachim A F Oude Vrielink; Ran Elkon; Reuven Agami
Journal:  Nat Cell Biol       Date:  2010-09-05       Impact factor: 28.824

3.  MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.

Authors:  Fangchao Gong; Ping Ren; Yan Zhang; Jindong Jiang; Hong Zhang
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

4.  Long Noncoding RNA uc.173 Promotes Renewal of the Intestinal Mucosa by Inducing Degradation of MicroRNA 195.

Authors:  Lan Xiao; Jing Wu; Jun-Yao Wang; Hee Kyoung Chung; Sudhakar Kalakonda; Jaladanki N Rao; Myriam Gorospe; Jian-Ying Wang
Journal:  Gastroenterology       Date:  2017-10-16       Impact factor: 22.682

5.  Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression.

Authors:  H Kawashima; T Numakawa; E Kumamaru; N Adachi; H Mizuno; M Ninomiya; H Kunugi; K Hashido
Journal:  Neuroscience       Date:  2009-12-01       Impact factor: 3.590

6.  IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1.

Authors:  Yeun-Ting Hsieh; Min-Min Chou; Hong-Chen Chen; Jenn-Jhy Tseng
Journal:  Gynecol Oncol       Date:  2013-08-01       Impact factor: 5.482

7.  β-PIX plays an important role in regulation of intestinal epithelial restitution by interacting with GIT1 and Rac1 after wounding.

Authors:  Navneeta Rathor; Hee Kyoung Chung; Shelley R Wang; Michael Qian; Douglas J Turner; Jian-Ying Wang; Jaladanki N Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-11-30       Impact factor: 4.052

8.  Blocking beta-catenin binding to the ZBP1 promoter represses ZBP1 expression, leading to increased proliferation and migration of metastatic breast-cancer cells.

Authors:  Wei Gu; Feng Pan; Robert H Singer
Journal:  J Cell Sci       Date:  2009-06-01       Impact factor: 5.285

9.  Regulation of cyclin-dependent kinase 4 translation through CUG-binding protein 1 and microRNA-222 by polyamines.

Authors:  Lan Xiao; Yu-Hong Cui; Jaladanki N Rao; Tongtong Zou; Lan Liu; Alexis Smith; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Mol Biol Cell       Date:  2011-07-07       Impact factor: 4.138

10.  miRNA-196b inhibits cell proliferation and induces apoptosis in HepG2 cells by targeting IGF2BP1.

Authors:  Magali Rebucci; Audrey Sermeus; Elodie Leonard; Edouard Delaive; Marc Dieu; Maude Fransolet; Thierry Arnould; Carine Michiels
Journal:  Mol Cancer       Date:  2015-04-08       Impact factor: 27.401

View more
  3 in total

1.  miR-195 regulates intestinal epithelial restitution after wounding by altering actin-related protein-2 translation.

Authors:  Shelley R Wang; Navneeta Rathor; Min S Kwon; Lan Xiao; Hee Kyoung Chung; Douglas J Turner; Jian-Ying Wang; Jaladanki N Rao
Journal:  Am J Physiol Cell Physiol       Date:  2022-03-02       Impact factor: 4.249

2.  TRPC1-mediated Ca2+ signaling enhances intestinal epithelial restitution by increasing α4 association with PP2Ac after wounding.

Authors:  Navneeta Rathor; Hee Kyoung Chung; Jia-Le Song; Shelley R Wang; Jian-Ying Wang; Jaladanki N Rao
Journal:  Physiol Rep       Date:  2021-05

3.  Circular RNA_0078767 upregulates Kruppel-like factor 9 expression by targeting microRNA-889, thereby inhibiting the progression of osteosarcoma.

Authors:  Qiu Chen; Haishen Zhou; Weihao Rong
Journal:  Bioengineered       Date:  2022-06       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.